US Export Ban on Vaccine Raw Material Could Hit Supply: SII Seeks Govt Intervention | CRUX

Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, has sought the Centre's intervention so as to enable the firm to import essential raw materials from the US for uninterrupted manufacturing and supply of COVID-19 vaccines.
In a letter to Commerce Secretary Anup Wadhawan and Foreign Secretary Harsh Vardhan Shringla, the director of the government and regulatory affairs department at Pune-based SII said the US government has invoked the Defence Production Act because of which the firm is facing difficulties in importing necessary products like cell culture medias, raw material, single-use tubing assemblies and some specialty chemicals from the US.
#Covishield #CovidVaccine #AdarPoonawalla
Crux is your daily dose of the big, viral and relevant news in a few minutes. It’s your ultimate guide to staying informed on the latest in politics, international relations, sports, entertainment and social media

Follow CRUX on Instagram (@crux.india): https://bit.ly/3qSFx1K
Follow CRUX on Facebook: https://bit.ly/2Lte7iF
#GetCloserToTheNews with latest headlines on politics, sports and entertainment on news18.com https://bit.ly/2Y4QccL

Also watch:
Crux One Take: https://bit.ly/3oNaLWf
Crux Files: https://bit.ly/3mnbnjW
Crux BTS: https://bit.ly/3oCjbQE

Видео US Export Ban on Vaccine Raw Material Could Hit Supply: SII Seeks Govt Intervention | CRUX канала CRUX